Fidelis Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $976K | Sell |
21,778
-1,215
| -5% | -$54.5K | 0.09% | 176 |
|
|
2025
Q1 | $1.1M | Buy |
22,993
+10,099
| +78% | +$484K | 0.12% | 144 |
|
|
2024
Q4 | $773K | Buy |
12,894
+813
| +7% | +$48.7K | 0.08% | 193 |
|
|
2024
Q3 | $641K | Sell |
12,081
-987
| -8% | -$52.4K | 0.08% | 207 |
|
|
2024
Q2 | $608K | Buy |
13,068
+6,007
| +85% | +$279K | 0.09% | 190 |
|
|
2024
Q1 | $383K | Buy |
7,061
+239
| +4% | +$13K | 0.06% | 246 |
|
|
2023
Q4 | $350K | Buy |
6,822
+2,491
| +58% | +$128K | 0.08% | 221 |
|
|
2023
Q3 | $251K | Sell |
4,331
-2,014
| -32% | -$117K | 0.09% | 223 |
|
|
2023
Q2 | $406K | Buy |
6,345
+319
| +5% | +$20.4K | 0.15% | 155 |
|
|
2023
Q1 | $411K | Buy |
+6,026
| New | +$411K | 0.17% | 141 |
|